Efficacy And Safety Of Indacaterol 75 G Once Daily In Patients With Moderate-To-Severe COPD

被引：0
|
作者：
Kerwin, E. M.
Meli, J.
Peckitt, C.
Lassen, C.
Kramer, B.
Filcek, S.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1595
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Efficacy And Safety Of Glycopyrronium In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem1 Study
    LaForce, C.
    Pearle, J.
    Feldman, G.
    Spangenthal, S.
    Eckert, J. H.
    Mota, F.
    Henley, M.
    D'Andrea, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [32] Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
    Hanania, Nicola A.
    Sethi, Sanjay
    Koltun, Arkady
    Ward, Jonathan K.
    Spanton, Jacqui
    Ng, Dik
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 117 - 127
  • [33] Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety
    Lain, Edward
    Day, Doris
    Harper, Julie
    Guenin, Eric
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (11) : 1128 - 1138
  • [34] DUAL-BRONCHODILATION WITH ONCE-DAILY QVA149 IN PATIENTS WITH MODERATE-TO-SEVERE COPD: OVERVIEW OF THE IGNITE PROGRAM
    Price, D.
    Mezzi, K.
    Fedele, M. J.
    Chen, H.
    Banerji, D.
    THORAX, 2013, 68 : A183 - A184
  • [35] Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study
    LaForce, Craig
    Feldman, Gregory
    Spangenthal, Selwyn
    Eckert, Joerg H.
    Henley, Michelle
    Patalano, Francesco
    D'Andrea, Peter
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1233 - 1243
  • [36] EFFICACY AND SAFETY OF ONCE-DAILY ACLIDINIUM BROMIDE 200 μG IN COMBINATION WITH FORMOTEROL IN PATIENTS WITH COPD
    Sliwinski, P.
    Perng, D-W
    Chuchalin, A.
    Jones, P. W.
    THORAX, 2010, 65 : A136 - A136
  • [37] Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study
    Wang, Chen
    Sun, Tieying
    Huang, Yijiang
    Humphries, Michael
    Bai, Lingyan
    Li, Lilly
    Wang, Qian
    Kho, Pearl
    Firth, Roz
    D'Andrea, Peter
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 57 - 68
  • [38] Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective
    Kerwin, Edward M.
    Williams, James
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 7 (01) : 25 - 37
  • [39] Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD (vol 7, pg 729, 2012)
    Buhl, R.
    Banerji, D.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 287 - 287
  • [40] Individual and differential treatment responses to once-daily long acting bronchodilators, glycopirronium and indacaterol, and combination of both drugs in the patients with moderate or severe COPD
    Ishii, Yoshiki
    Takemasa, Akihiro
    Chibana, Kazuyuki
    Arai, Ryo
    Shiobara, Taichi
    Watanabe, Taiji
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345